产品详情
文献和实验
相关推荐
南京肽业 多肽产品展销 欢迎惠顾！liugang@njpeptide.com,025-58361107-805
Histone deacetylase,HDAC substrate??||Histone deacetylase,HDAC substrate??|Ac-RGK(Ac)-AMC|liugang@njpeptide.com,025-58361107-805
Histone H1 -derived peptide||Histone H1 -derived peptide|Gly-Gly-Gly-Pro-Ala-Thr-Pro-Lys-Lys-Ala-Lys-Lys-Leu|liugang@njpeptide.com,025-58361107-805
Histone H1-derived peptide,FAM-labeled??||Histone H1-derived peptide,FAM-labeled??|5-FAM-GGGPATPKKAKKL-OH|liugang@njpeptide.com,025-58361107-805
Histone H1-derived peptide,phosphorylated??||Histone H1-derived peptide,phosphorylated??|GGGPA-pT-PKKAKKL-OH|liugang@njpeptide.com,025-58361107-805
Histone H1-derived peptide,TAMRA labeled??||Histone H1-derived peptide,TAMRA labeled??|5-TAMRA-GGGPATPKKAKKL-OH|liugang@njpeptide.com,025-58361107-805
Histone H2B (29-35)||Histone H2B (29-35)||liugang@njpeptide.com,025-58361107-805
Histone H3 (1 -25),amide||Histone H3 (1 -25),amide|Ala-Arg-Thr-Lys-Gln-Thr-Ala-Arg-Lys-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Arg-Lys-Gln-Leu-Ala-Thr-Lys-Ala-Ala--NH2|liugang@njpeptide.com,025-58361107-805
Histone H3 (1-21),Biotinated??||Histone H3 (1-21),Biotinated??|ARTKQTARKSTGGKAPRKQLA-GG-K(BIOTIN)-NH2|liugang@njpeptide.com,025-58361107-805
Histone H3 (1-21),N-Terminal??||Histone H3 (1-21),N-Terminal??|ARTKQTARKSTGGKAPRKQLA|liugang@njpeptide.com,025-58361107-805
Histone H3 (1-25),amide,??||Histone H3 (1-25),amide,??|ARTKQTARKSTGGKAPRKQLATKAA-NH2|liugang@njpeptide.com,025-58361107-805
Histone H3 (116–136), C116–136||Histone H3 (116–136), C116–136|Lys-Arg-Val-Thr-Ile-Met-Pro-Lys-Asp-Ile-Gln-Leu-Ala-Arg-Arg-Ile-Arg-Gly-Glu-Arg-Ala|liugang@njpeptide.com,025-58361107-805
Histone H3 (116–136), N15–39||Histone H3 (116–136), N15–39|Ala-Pro-Arg-Lys-Gln-Leu-Ala-Thr-Lys-Ala-Ala-Arg-Lys-Ser-Ala-Pro-Ala-Thr-Gly-Gly-Val-Lys-Lys-Pro-His|liugang@njpeptide.com,025-58361107-805
Histone H3 (116–136),C116–136||KRVTIMPKDIQLARRIRGERA|LYS-ARG-VAL-THR-ILE-MET-PRO-LYS-ASP-ILE-GLN-LEU-ALA-ARG-ARG-ILE-ARG-GLY-GLU-ARG-ALA|liugang@njpeptide.com,025-58361107-805
HIV (gp120) Antigenic Peptide ||HIV (gp120) Antigenic Peptide |HIV(gp120)AntigenicPeptide|liugang@njpeptide.com,025-58361107-805
HIV (gp120) Fragment (254-274) ||HIV (gp120) Fragment (254-274) |HIV(gp120)Fragment(254-274)|liugang@njpeptide.com,025-58361107-805
HIV (GP120) FRAGMENT (254-274); HIV Peptide gp120 (254-274)|113944-46-0|HIV (GP120) FRAGMENT (254-274); HIV Peptide gp120 (254-274)|CYS-THR-HIS-GLY-ILE-ARG-PRO-VAL-VAL-SER-THR-GLN-LEU-LEU-LEU-ASN-GLY-SER-LEU-ALA-GLU|liugang@njpeptide.com,025-58361107-805
HIV (gp120) Fragment (308-331) |115416-08-5|HIV (gp120) Fragment (308-331) |ASN-ASN-THR-ARG-LYS-SER-ILE-ARG-ILE-GLN-ARG-GLY-PRO-GLY-ARG-ALA-PHE-VAL-THR-ILE-GLY-LYS-ILE-GLY|liugang@njpeptide.com,025-58361107-805
HIV (GP120) FRAGMENT (315-329),HIV-1 env Protein gp120 (278-292) (strains BH10,BH8,HXB2,HXB3,PV22) |114991-28-5|HIV (GP120) FRAGMENT (315-329),HIV-1 env Protein gp120 (278-292) (strains BH10,BH8,HXB2,HXB3,PV22) |ARG-ILE-GLN-ARG-GLY-PRO-GLY-ARG-ALA-PHE-VAL-THR-ILE-GLY-LYS|liugang@njpeptide.com,025-58361107-805
HIV (gp120) Fragment (318-327) ||HIV (gp120) Fragment (318-327) |HIV(gp120)Fragment(318-327)|liugang@njpeptide.com,025-58361107-805
HIV (gp41) Antigenic Peptide 5 ||HIV (gp41) Antigenic Peptide 5 |HIV(gp41)AntigenicPeptide5|liugang@njpeptide.com,025-58361107-805
HIV (gp41) Fragment ||HIV (gp41) Fragment |H-ALA-VAL-GLY-ILE-GLY-ALA-OH|liugang@njpeptide.com,025-58361107-805
HIV (GP41) FRAGMENT (519-541)||HIV (GP41) FRAGMENT (519-541)||liugang@njpeptide.com,025-58361107-805
HIV -gp120- Antigenic Peptide|198636-94-1|HIV -gp120- Antigenic Peptide|Cys-Gly-Lys-Ile-Glu-Pro-Leu-Gly-Val-Ala-Pro-Thr-Lys-Ala-Lys-Arg-Arg-Val-Val-Gln-Arg-Glu-Lys-Arg|liugang@njpeptide.com,025-58361107-805
HIV -gp120- Fragment (421-438)||HIV -gp120- Fragment (421-438)|Lys-Gln-Phe-Ile-Asn-Met-Trp-Gln-Glu-Val-Gly-Lys-Ala-Met-Tyr-Ala-Pro-Pro|liugang@njpeptide.com,025-58361107-805
HIV -gp120-Fragment (254-274)||HIV -gp120-Fragment (254-274)|Cys-Thr-His-Gly-Ile-Arg-Pro-Val-Val-Ser-Thr-Gln-Leu-Leu-Leu-Asn-Gly-Ser-Leu-Ala-Glu|liugang@njpeptide.com,025-58361107-805
HIV Envelope Peptide GP 120, (307-330)||HIV Envelope Peptide GP 120, (307-330)||liugang@njpeptide.com,025-58361107-805
HIV gag p24 peptide (197-205)||HIV gag p24 peptide (197-205)||liugang@njpeptide.com,025-58361107-805
HIV Integrase Protein Inhibitor(1)|172546-75-7|HIV Integrase Protein Inhibitor(1)|H-HIS-CYS-LYS-PHE-TRP-TRP-OH|liugang@njpeptide.com,025-58361107-805
HIV MN#22||HIV MN#22|PKISFEPIPIHYCAPAGFAI|liugang@njpeptide.com,025-58361107-805
HIV Nef(90-100)??||FLKEKGGLEGL|Phe-Leu-Lys-Glu-Lys-Gly-Gly-Leu-Glu-Gly-Leu|liugang@njpeptide.com,025-58361107-805
HIV Peptide gp120 (254-274)||HIV Peptide gp120 (254-274)|HIVPeptidegp120(254-274)|liugang@njpeptide.com,025-58361107-805
HIV Protease Assay Kit ||HIV Protease Assay Kit |HIVPROTEASEASSAYKIT|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate I||SENYPIV|SER-GLU-ASN-TYR-PRO-ILE-VAL:SENYPIV|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate II |120944-74-3|HIV Protease Substrate II |HIVPROTEASESUBSTRATEII|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate III|138608-20-5|HIV Protease Substrate III|HIVPROTEASESUBSTRATEIII|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate III-B (Native Sequence) ||HIV Protease Substrate III-B (Native Sequence) |HIVPROTEASESUBSTRATEIII-B(NATIVESEQUENCE)|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate IV ||HIV Protease Substrate IV |HIVProteaseSubstrateIV|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate V ||HIV Protease Substrate V |HIVPROTEASESUBSTRATEV|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate VI ||HIV Protease Substrate VI |HIVPROTEASESUBSTRATEVI|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate VII ||HIV Protease Substrate VII |HIVPROTEASESUBSTRATEVII|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate VIII ||HIV Protease Substrate VIII |HIVPROTEASESUBSTRATEVIII|liugang@njpeptide.com,025-58361107-805
HIV Protein Reverse Transcriptase Peptide (RT33-41)||HIV Protein Reverse Transcriptase Peptide (RT33-41)|ALVEICTEM|liugang@njpeptide.com,025-58361107-805
HIV QK10||QVPLRMTYK|Gln-Val-Pro-Leu-Arg-Met-Thr-Tyr-Lys|liugang@njpeptide.com,025-58361107-805
HIV Related Peptides||HIV Related Peptides|HIVRELATEDPEPTIDES|liugang@njpeptide.com,025-58361107-805
HIV Substrate||HIV Substrate|KARVNleF(4-NO2)EANle-NH2|liugang@njpeptide.com,025-58361107-805
HIV Substrate|128340-47-6|HIV Substrate|Ac-Ala-Arg-Val-Leu-Ala-Glu-Ala-NH2|liugang@njpeptide.com,025-58361107-805
HIV Substrate IV||HIV Substrate IV||liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-1||HIV-1 CONSENSUS B VIF-1|MENRWQVMIVWQVDR|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-10||HIV-1 CONSENSUS B VIF-10|GWFYRHHYESTHPRI|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-11||HIV-1 CONSENSUS B VIF-11|RHHYESTHPRISSEV|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-12||HIV-1 CONSENSUS B VIF-12|ESTHPRISSEVHIPL|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-13||HIV-1 CONSENSUS B VIF-13|PRISSEVHIPLGDAK|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-14||HIV-1 CONSENSUS B VIF-14|SEVHIPLGDAKLVIT|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-15||HIV-1 CONSENSUS B VIF-15|IPLGDAKLVITTYWG|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-16||HIV-1 CONSENSUS B VIF-16|DAKLVITTYWGLHTG|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-17||HIV-1 CONSENSUS B VIF-17|VITTYWGLHTGERDW|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-18||HIV-1 CONSENSUS B VIF-18|YWGLHTGERDWHLGQ|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-19||HIV-1 CONSENSUS B VIF-19|HTGERDWHLGQGVSI|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-2||HIV-1 CONSENSUS B VIF-2|WQVMIVWQVDRMRIR|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-20||HIV-1 CONSENSUS B VIF-20|RDWHLGQGVSIEWRK|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-21||HIV-1 CONSENSUS B VIF-21|LGQGVSIEWRKKRYS|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-22||HIV-1 CONSENSUS B VIF-22|VSIEWRKKRYSTQVD|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-23||HIV-1 CONSENSUS B VIF-23|WRKKRYSTQVDPDLA|liugang@njpeptide.com,025-58361107-805
欢迎联系南京肽业（www.njpeptide.com），我们专注于多肽产品，如果您需要其他相关多肽产品或者多肽定制服务，我们可以帮您进行定制合成。liugang@njpeptide.com|18751911884|025-58361107-805 |QQ:467172867|国内服务区域:北京·天津·上海·重庆·西藏（拉萨等）·内蒙古（呼和浩特等）·新疆（乌鲁木齐等）·广西（南宁等）·宁夏（银川等）·辽宁（大连等）·吉林（长春等）·黑龙江（哈尔滨等） ·河北（石家庄等）·山西（太原等）·陕西（西安等）·江苏（南京、常州、无锡、苏州等）·浙江（杭州、宁波、温州等）·福建（福州、厦门等）·安徽（合肥等）·江西(南昌等)·山东（济南、青岛、烟台等）·河南(郑州、洛阳等)·湖北（武汉等）·湖南(长沙等)·广东（广州深圳珠海等）·海南(海口等)·四川（成都等）·贵州(贵阳 等)·云南(昆明等)·甘肃(兰州等)·青海(西宁等).
Histone deacetylase,HDAC substrate??||Histone deacetylase,HDAC substrate??|Ac-RGK(Ac)-AMC|liugang@njpeptide.com,025-58361107-805
Histone H1 -derived peptide||Histone H1 -derived peptide|Gly-Gly-Gly-Pro-Ala-Thr-Pro-Lys-Lys-Ala-Lys-Lys-Leu|liugang@njpeptide.com,025-58361107-805
Histone H1-derived peptide,FAM-labeled??||Histone H1-derived peptide,FAM-labeled??|5-FAM-GGGPATPKKAKKL-OH|liugang@njpeptide.com,025-58361107-805
Histone H1-derived peptide,phosphorylated??||Histone H1-derived peptide,phosphorylated??|GGGPA-pT-PKKAKKL-OH|liugang@njpeptide.com,025-58361107-805
Histone H1-derived peptide,TAMRA labeled??||Histone H1-derived peptide,TAMRA labeled??|5-TAMRA-GGGPATPKKAKKL-OH|liugang@njpeptide.com,025-58361107-805
Histone H2B (29-35)||Histone H2B (29-35)||liugang@njpeptide.com,025-58361107-805
Histone H3 (1 -25),amide||Histone H3 (1 -25),amide|Ala-Arg-Thr-Lys-Gln-Thr-Ala-Arg-Lys-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Arg-Lys-Gln-Leu-Ala-Thr-Lys-Ala-Ala--NH2|liugang@njpeptide.com,025-58361107-805
Histone H3 (1-21),Biotinated??||Histone H3 (1-21),Biotinated??|ARTKQTARKSTGGKAPRKQLA-GG-K(BIOTIN)-NH2|liugang@njpeptide.com,025-58361107-805
Histone H3 (1-21),N-Terminal??||Histone H3 (1-21),N-Terminal??|ARTKQTARKSTGGKAPRKQLA|liugang@njpeptide.com,025-58361107-805
Histone H3 (1-25),amide,??||Histone H3 (1-25),amide,??|ARTKQTARKSTGGKAPRKQLATKAA-NH2|liugang@njpeptide.com,025-58361107-805
Histone H3 (116–136), C116–136||Histone H3 (116–136), C116–136|Lys-Arg-Val-Thr-Ile-Met-Pro-Lys-Asp-Ile-Gln-Leu-Ala-Arg-Arg-Ile-Arg-Gly-Glu-Arg-Ala|liugang@njpeptide.com,025-58361107-805
Histone H3 (116–136), N15–39||Histone H3 (116–136), N15–39|Ala-Pro-Arg-Lys-Gln-Leu-Ala-Thr-Lys-Ala-Ala-Arg-Lys-Ser-Ala-Pro-Ala-Thr-Gly-Gly-Val-Lys-Lys-Pro-His|liugang@njpeptide.com,025-58361107-805
Histone H3 (116–136),C116–136||KRVTIMPKDIQLARRIRGERA|LYS-ARG-VAL-THR-ILE-MET-PRO-LYS-ASP-ILE-GLN-LEU-ALA-ARG-ARG-ILE-ARG-GLY-GLU-ARG-ALA|liugang@njpeptide.com,025-58361107-805
HIV (gp120) Antigenic Peptide ||HIV (gp120) Antigenic Peptide |HIV(gp120)AntigenicPeptide|liugang@njpeptide.com,025-58361107-805
HIV (gp120) Fragment (254-274) ||HIV (gp120) Fragment (254-274) |HIV(gp120)Fragment(254-274)|liugang@njpeptide.com,025-58361107-805
HIV (GP120) FRAGMENT (254-274); HIV Peptide gp120 (254-274)|113944-46-0|HIV (GP120) FRAGMENT (254-274); HIV Peptide gp120 (254-274)|CYS-THR-HIS-GLY-ILE-ARG-PRO-VAL-VAL-SER-THR-GLN-LEU-LEU-LEU-ASN-GLY-SER-LEU-ALA-GLU|liugang@njpeptide.com,025-58361107-805
HIV (gp120) Fragment (308-331) |115416-08-5|HIV (gp120) Fragment (308-331) |ASN-ASN-THR-ARG-LYS-SER-ILE-ARG-ILE-GLN-ARG-GLY-PRO-GLY-ARG-ALA-PHE-VAL-THR-ILE-GLY-LYS-ILE-GLY|liugang@njpeptide.com,025-58361107-805
HIV (GP120) FRAGMENT (315-329),HIV-1 env Protein gp120 (278-292) (strains BH10,BH8,HXB2,HXB3,PV22) |114991-28-5|HIV (GP120) FRAGMENT (315-329),HIV-1 env Protein gp120 (278-292) (strains BH10,BH8,HXB2,HXB3,PV22) |ARG-ILE-GLN-ARG-GLY-PRO-GLY-ARG-ALA-PHE-VAL-THR-ILE-GLY-LYS|liugang@njpeptide.com,025-58361107-805
HIV (gp120) Fragment (318-327) ||HIV (gp120) Fragment (318-327) |HIV(gp120)Fragment(318-327)|liugang@njpeptide.com,025-58361107-805
HIV (gp41) Antigenic Peptide 5 ||HIV (gp41) Antigenic Peptide 5 |HIV(gp41)AntigenicPeptide5|liugang@njpeptide.com,025-58361107-805
HIV (gp41) Fragment ||HIV (gp41) Fragment |H-ALA-VAL-GLY-ILE-GLY-ALA-OH|liugang@njpeptide.com,025-58361107-805
HIV (GP41) FRAGMENT (519-541)||HIV (GP41) FRAGMENT (519-541)||liugang@njpeptide.com,025-58361107-805
HIV -gp120- Antigenic Peptide|198636-94-1|HIV -gp120- Antigenic Peptide|Cys-Gly-Lys-Ile-Glu-Pro-Leu-Gly-Val-Ala-Pro-Thr-Lys-Ala-Lys-Arg-Arg-Val-Val-Gln-Arg-Glu-Lys-Arg|liugang@njpeptide.com,025-58361107-805
HIV -gp120- Fragment (421-438)||HIV -gp120- Fragment (421-438)|Lys-Gln-Phe-Ile-Asn-Met-Trp-Gln-Glu-Val-Gly-Lys-Ala-Met-Tyr-Ala-Pro-Pro|liugang@njpeptide.com,025-58361107-805
HIV -gp120-Fragment (254-274)||HIV -gp120-Fragment (254-274)|Cys-Thr-His-Gly-Ile-Arg-Pro-Val-Val-Ser-Thr-Gln-Leu-Leu-Leu-Asn-Gly-Ser-Leu-Ala-Glu|liugang@njpeptide.com,025-58361107-805
HIV Envelope Peptide GP 120, (307-330)||HIV Envelope Peptide GP 120, (307-330)||liugang@njpeptide.com,025-58361107-805
HIV gag p24 peptide (197-205)||HIV gag p24 peptide (197-205)||liugang@njpeptide.com,025-58361107-805
HIV Integrase Protein Inhibitor(1)|172546-75-7|HIV Integrase Protein Inhibitor(1)|H-HIS-CYS-LYS-PHE-TRP-TRP-OH|liugang@njpeptide.com,025-58361107-805
HIV MN#22||HIV MN#22|PKISFEPIPIHYCAPAGFAI|liugang@njpeptide.com,025-58361107-805
HIV Nef(90-100)??||FLKEKGGLEGL|Phe-Leu-Lys-Glu-Lys-Gly-Gly-Leu-Glu-Gly-Leu|liugang@njpeptide.com,025-58361107-805
HIV Peptide gp120 (254-274)||HIV Peptide gp120 (254-274)|HIVPeptidegp120(254-274)|liugang@njpeptide.com,025-58361107-805
HIV Protease Assay Kit ||HIV Protease Assay Kit |HIVPROTEASEASSAYKIT|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate I||SENYPIV|SER-GLU-ASN-TYR-PRO-ILE-VAL:SENYPIV|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate II |120944-74-3|HIV Protease Substrate II |HIVPROTEASESUBSTRATEII|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate III|138608-20-5|HIV Protease Substrate III|HIVPROTEASESUBSTRATEIII|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate III-B (Native Sequence) ||HIV Protease Substrate III-B (Native Sequence) |HIVPROTEASESUBSTRATEIII-B(NATIVESEQUENCE)|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate IV ||HIV Protease Substrate IV |HIVProteaseSubstrateIV|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate V ||HIV Protease Substrate V |HIVPROTEASESUBSTRATEV|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate VI ||HIV Protease Substrate VI |HIVPROTEASESUBSTRATEVI|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate VII ||HIV Protease Substrate VII |HIVPROTEASESUBSTRATEVII|liugang@njpeptide.com,025-58361107-805
HIV Protease Substrate VIII ||HIV Protease Substrate VIII |HIVPROTEASESUBSTRATEVIII|liugang@njpeptide.com,025-58361107-805
HIV Protein Reverse Transcriptase Peptide (RT33-41)||HIV Protein Reverse Transcriptase Peptide (RT33-41)|ALVEICTEM|liugang@njpeptide.com,025-58361107-805
HIV QK10||QVPLRMTYK|Gln-Val-Pro-Leu-Arg-Met-Thr-Tyr-Lys|liugang@njpeptide.com,025-58361107-805
HIV Related Peptides||HIV Related Peptides|HIVRELATEDPEPTIDES|liugang@njpeptide.com,025-58361107-805
HIV Substrate||HIV Substrate|KARVNleF(4-NO2)EANle-NH2|liugang@njpeptide.com,025-58361107-805
HIV Substrate|128340-47-6|HIV Substrate|Ac-Ala-Arg-Val-Leu-Ala-Glu-Ala-NH2|liugang@njpeptide.com,025-58361107-805
HIV Substrate IV||HIV Substrate IV||liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-1||HIV-1 CONSENSUS B VIF-1|MENRWQVMIVWQVDR|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-10||HIV-1 CONSENSUS B VIF-10|GWFYRHHYESTHPRI|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-11||HIV-1 CONSENSUS B VIF-11|RHHYESTHPRISSEV|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-12||HIV-1 CONSENSUS B VIF-12|ESTHPRISSEVHIPL|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-13||HIV-1 CONSENSUS B VIF-13|PRISSEVHIPLGDAK|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-14||HIV-1 CONSENSUS B VIF-14|SEVHIPLGDAKLVIT|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-15||HIV-1 CONSENSUS B VIF-15|IPLGDAKLVITTYWG|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-16||HIV-1 CONSENSUS B VIF-16|DAKLVITTYWGLHTG|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-17||HIV-1 CONSENSUS B VIF-17|VITTYWGLHTGERDW|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-18||HIV-1 CONSENSUS B VIF-18|YWGLHTGERDWHLGQ|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-19||HIV-1 CONSENSUS B VIF-19|HTGERDWHLGQGVSI|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-2||HIV-1 CONSENSUS B VIF-2|WQVMIVWQVDRMRIR|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-20||HIV-1 CONSENSUS B VIF-20|RDWHLGQGVSIEWRK|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-21||HIV-1 CONSENSUS B VIF-21|LGQGVSIEWRKKRYS|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-22||HIV-1 CONSENSUS B VIF-22|VSIEWRKKRYSTQVD|liugang@njpeptide.com,025-58361107-805
HIV-1 CONSENSUS B VIF-23||HIV-1 CONSENSUS B VIF-23|WRKKRYSTQVDPDLA|liugang@njpeptide.com,025-58361107-805
欢迎联系南京肽业（www.njpeptide.com），我们专注于多肽产品，如果您需要其他相关多肽产品或者多肽定制服务，我们可以帮您进行定制合成。liugang@njpeptide.com|18751911884|025-58361107-805 |QQ:467172867|国内服务区域:北京·天津·上海·重庆·西藏（拉萨等）·内蒙古（呼和浩特等）·新疆（乌鲁木齐等）·广西（南宁等）·宁夏（银川等）·辽宁（大连等）·吉林（长春等）·黑龙江（哈尔滨等） ·河北（石家庄等）·山西（太原等）·陕西（西安等）·江苏（南京、常州、无锡、苏州等）·浙江（杭州、宁波、温州等）·福建（福州、厦门等）·安徽（合肥等）·江西(南昌等)·山东（济南、青岛、烟台等）·河南(郑州、洛阳等)·湖北（武汉等）·湖南(长沙等)·广东（广州深圳珠海等）·海南(海口等)·四川（成都等）·贵州(贵阳 等)·云南(昆明等)·甘肃(兰州等)·青海(西宁等).
南京肽业生物科技有限公司
实名认证
皇冠会员
入驻年限：10年
